Andrew Left’s Citron Capital posted net return of 24.7% in 1st half of 2019
Andrew Left’s Citron Capital posted a net return of 24.7% after fees and expenses in the first half of 2019, according to an investment letter...
Global stocks fall on trade, earnings worry; U.S. Treasury yields fall
A gauge of global stocks declined for a second straight session and U.S. Treasury yields fell as trade concerns began to percolate and the pace...
Andrew Left’s Citron Capital posted net return of 24.7% in first half of 2019
Andrew Left’s Citron Capital posted a net return of 24.7% after fees and expenses in the first half of 2019, according to an investment letter...
Oil prices fall more than 1% after U.S. fuel inventories build
Oil futures fell more than 1% on Wednesday, extending a more than 3% drop in prices the previous session, after U.S. government data showed large...
Another $860 million recovered for Madoff customers in Kingate settlement: trustee
The court-appointed trustee liquidating Bernard Madoff’s firm on Wednesday said another $860 million may soon be returned to the swindler’s customers, under a settlement with...
Paint makers reach $305 million settlement in California, ending marathon lead poisoning lawsuit
After a 19-year legal struggle, three former makers of lead paint have agreed to a $305 million settlement with California county and city governments to...
Takeda kicks off sale of Western European drugs: sources
Japan’s Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim...
Oil prices edge lower after U.S. fuel inventories build
Oil futures fell on Wednesday, extending a more than 3% drop in prices the previous session, after U.S. government data showed large builds in refined...
Trade concerns dent stocks; U.S. Treasury yields fall
A gauge of global stocks declined for a second straight session and U.S. Treasury yields fell as trade concerns again began to bubble and U.S....
Abbott hits record high as diabetes device fuels profit beat
Abbott Laboratories beat analysts’ estimates for quarterly profit and lifted its full-year earnings forecast on Wednesday, boosted by a near 64% jump in sales of...